These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38643333)
1. FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner. Yin Z; Guo X; Liang X; Wang Z Med Oncol; 2024 Apr; 41(5):120. PubMed ID: 38643333 [TBL] [Abstract][Full Text] [Related]
2. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer. Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402 [TBL] [Abstract][Full Text] [Related]
3. RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer. Lai Y; Dong H; Xu P; Wang J; Feng W; Zhao Z; Sha L BMC Gastroenterol; 2024 Jan; 24(1):29. PubMed ID: 38200441 [TBL] [Abstract][Full Text] [Related]
4. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway. Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267 [TBL] [Abstract][Full Text] [Related]
5. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer. Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129 [TBL] [Abstract][Full Text] [Related]
6. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314 [TBL] [Abstract][Full Text] [Related]
7. Fat mass and obesity-associated protein (FTO) mediated m Wu X; Fang Y; Gu Y; Shen H; Xu Y; Xu T; Shi R; Xu D; Zhang J; Leng K; Shu Y; Ma P Mol Biomed; 2024 Apr; 5(1):11. PubMed ID: 38556586 [TBL] [Abstract][Full Text] [Related]
8. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3. Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957 [TBL] [Abstract][Full Text] [Related]
9. FTO facilitates cancer metastasis by modifying the m Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739 [TBL] [Abstract][Full Text] [Related]
10. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer. Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548 [TBL] [Abstract][Full Text] [Related]
11. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients. Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008 [TBL] [Abstract][Full Text] [Related]
12. AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation. Bian X; Shi D; Xing K; Zhou H; Lu L; Yu D; Wu W Clin Transl Med; 2021 Mar; 11(3):e352. PubMed ID: 33783988 [TBL] [Abstract][Full Text] [Related]
13. PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance. Zhang Y; Zhou X; Cheng X; Hong X; Jiang X; Jing G; Chen K; Li Y Neoplasma; 2022 Dec; 69(6):1338-1348. PubMed ID: 36305690 [TBL] [Abstract][Full Text] [Related]
14. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2. Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133 [TBL] [Abstract][Full Text] [Related]
15. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner. Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068 [TBL] [Abstract][Full Text] [Related]
16. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway. Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587 [TBL] [Abstract][Full Text] [Related]
17. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma. Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449 [TBL] [Abstract][Full Text] [Related]
18. Novel evidence for m Shimura T; Kandimalla R; Okugawa Y; Ohi M; Toiyama Y; He C; Goel A Br J Cancer; 2022 Feb; 126(2):228-237. PubMed ID: 34675398 [TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer. Wu J; Wang X; Li X Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224 [TBL] [Abstract][Full Text] [Related]